NASDAQ: MOBI
Mobia Medical, Inc.CIK 0001489993 · Surgical & Medical Instruments
Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.
Sign up freeWant to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.
Summary not yet generated.
Mobia Medical doubles Q1 revenue to $12.1M but discloses material weakness in EPS controls
5 material changes detected. Sign up free to read the summary.
Partner
Trade MOBI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Mobia Medical completes IPO, implements staggered board and anti-takeover provisions
5 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Jun 4, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.
Consolidated Statements of Operations (Unaudited)
| Description | Q1 ended Mar 31, 2026 | Q1 ended Mar 31, 2025 |
|---|---|---|
| Revenue: | ||
| Total revenue / net sales | 12.1 | 5.7 |
| Cost of revenue / cost of sales | 2.1 | 1.0 |
| Gross profit | 9.9 | 4.6 |
| Operating expenses: | ||
| Research and development | 1.7 | 1.4 |
| Selling, general and administrative | 25.2 | 13.6 |
| Total operating expenses | 26.9 | 14.9 |
| Operating income | (16.9) | (10.3) |
| Interest expense | 0.4 | 0.2 |
| Other income/(expense), net | (0.8) | (0.3) |
| Income before income taxes | (17.7) | (10.7) |
| Income tax expense/(benefit) | — | — |
| Net income | (17.7) | (10.7) |
| Basic earnings per share | (19.30) | (12.97) |
| Diluted earnings per share | (19.30) | (12.97) |
Consolidated Balance Sheets (Unaudited)
| Description | Mar 31, 2026 | Dec 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and equivalents | 55.7 | 33.6 |
| Accounts receivable, net | 4.9 | 4.4 |
| Inventories | 6.0 | 5.5 |
| Prepaid expenses and other current assets | 1.6 | 1.9 |
| Other current assets | 3.5 | 0.9 |
| Total current assets | 71.7 | 46.4 |
| Property, plant and equipment, net | 0.7 | 0.7 |
| Operating lease right-of-use assets, net | 1.0 | 1.1 |
| Deferred income taxes and other assets | 0.1 | 0.06 |
| TOTAL ASSETS | 73.6 | 48.1 |
| Current liabilities: | ||
| Accounts payable | 3.0 | 2.2 |
| Current portion of operating lease liabilities | 0.4 | 0.4 |
| Other current liabilities | 8.4 | 7.6 |
| Total current liabilities | 11.8 | 10.2 |
| Operating lease liabilities | 0.9 | 0.9 |
| Other long-term liabilities | 48.9 | 8.0 |
| Total liabilities | 61.6 | 19.1 |
| Redeemable preferred stock | 179.8 | 179.8 |
| Shareholders' equity: | ||
| Common stock | 0.01 | 0.01 |
| Capital in excess of stated value | 7.8 | 7.0 |
| Retained earnings (deficit) | (175.5) | (157.8) |
| Total shareholders' equity | (167.7) | (150.8) |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 73.6 | 48.1 |
Consolidated Statements of Cash Flows (Unaudited)
| Description | Q1 ended Mar 31, 2026 | Q1 ended Mar 31, 2025 |
|---|---|---|
| Operating Activities: | ||
| Net cash from operating activities | (17.7) | (9.7) |
| Investing Activities: | ||
| Net cash from investing activities | (0.04) | (0.02) |
| Financing Activities: | ||
| Net cash from financing activities | 39.9 | 32.4 |
| Net increase/(decrease) in cash | 22.1 | 22.7 |
Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗